Can diabetes be cured? Potential biological and mechanical approaches

JAMA

Volumn 301, Issue 15, 2009, Pages 1588-1590

  Saudek, Christopher D ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ALGORITHM; ARTIFICIAL PANCREAS; DIABETES MELLITUS; GRAFT SURVIVAL; HUMAN; MEDICAL RESEARCH; NOTE; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; ARTICLE; BARIATRIC SURGERY; FORECASTING;

BARIATRIC SURGERY; BIOMEDICAL RESEARCH; DIABETES MELLITUS; FORECASTING; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; PANCREAS, ARTIFICIAL;

EID: 64749088594     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.508     Document Type: Note

References (15)

1. Waki K, Kadowaki T. An analysis of long-term survival from the OPTN/UNOS pancreas transplant registry. Clin Transpl. 2007:9-17.
2. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in 7 patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343(4):230-238.
3. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med. 2006;355(13):1318-1330.
4. Mallett AG, Korbutt GS. Alginate modification improves long-term survival and function of transplanted encapsulated islets [published online ahead of print October 24, 2008]. Tissue Eng Part A. doi:10.1089/ten.tea.2008. 0118.
5. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature. 2008;455(7213):627-632.
6. Bonner-Weir S, Inada A, Yatoh S, et al. Transdifferentiation of pancreatic ductal cells to endocrine beta-cells. Biochem Soc Trans. 2008;36(pt 3):353-356.
7. Herold KC, Hagopian W, Auger JA, et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med. 2002;346(22):1692-1698.
8. Bollyky J, Sanda S, Greenbaum CJ. Type 1 diabetes mellitus: primary, secondary, and tertiary prevention. Mt Sinai J Med. 2008;75(4):385-397.
9. Couri CEB, Oliveira MCB, Stracieri ABPL, et al. C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA. 2009;301(15): 1573-1579.
10. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008; 299(3):316-323.
11. Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244(5):741-749.
12. Tamborlane WV, Beck RW, Bode BW; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359(14): 1464-1476.
13. Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV. Fully automated closed-loop insulin delivery vs semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care. 2008; 31(5):934-939.
14. Saudek CD, Duckworth WC, Giobbie-Hurder A, et al; Department of Veterans Affairs Implantable Insulin Pump Study Group. Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. JAMA. 1996;276(16):1322-1327.
15. Resnick HE, Foster GL, Bardsley J, Ratner RE. Achievement of American Diabetes Association clinical practice recommendations among US adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey. Diabetes Care. 2006;29(3):531-537.